InvestSMART

Immuron Limited (ASX: IMC) - Announcements

- Current share price for IMC : $0.046

ASX company news and announcements for Immuron Limited (IMC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immuron Limited (IMC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immuron Limited (IMC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immuron Limited (IMC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$15 Half Yearly Report and Accounts 28 Feb 2019 9:50AM $0.260 $0.046 fallen by 82.31%
$15 Travelan FY19 Update and Expansion into North America 29 Jan 2019 9:59AM $0.265 $0.046 fallen by 82.64%
$15 Form F-3 15 Jan 2019 9:46AM $0.270 $0.046 fallen by 82.96%
$15 Immuron Receives $1.19M R&D Tax Concession Refund 3 Jan 2019 9:40AM $0.210 $0.046 fallen by 78.10%
$15 Change in substantial holding 29 Nov 2018 11:46AM $0.255 $0.046 fallen by 81.96%
$15 Form 604 - Change in Substantial Shareholding (Grandlodge) 27 Nov 2018 10:25AM $0.240 $0.046 fallen by 80.83%
$15 Appendix 3Y - Change of Director's Interest Notice (PA) 27 Nov 2018 10:23AM $0.240 $0.046 fallen by 80.83%
$15 Appendix 3Y - Change of Director's Interest Notice (RJB) 27 Nov 2018 10:22AM $0.240 $0.046 fallen by 80.83%
$15 Appendix 3B 27 Nov 2018 10:20AM $0.240 $0.046 fallen by 80.83%
$15 NASH clinical trial presentation & continued revenue growth 9 Nov 2018 3:43PM $0.280 $0.046 fallen by 83.57%
$15 Annual Report 2018 on Form 20-F & XBRL data filed with SEC 1 Nov 2018 9:40AM $0.270 $0.046 fallen by 82.96%
$15 IMC's CEO Interviewed in US on the RedChip Money Report 16 Oct 2018 9:43AM $0.310 $0.046 fallen by 85.16%
$15 Notice of Annual General Meeting/Proxy Form 11 Oct 2018 8:54AM $0.295 $0.046 fallen by 84.41%
$15 Notice of Annual General Meeting/Proxy Form 10 Oct 2018 9:18AM $0.295 $0.046 fallen by 84.41%
$15 Corporate Governance Statement 27 Sep 2018 4:35PM $0.335 $0.046 fallen by 86.27%
$15 Appendix 4G 27 Sep 2018 4:34PM $0.335 $0.046 fallen by 86.27%
$15 Annual Report 27 Sep 2018 4:34PM $0.335 $0.046 fallen by 86.27%
$15 US DoD Report Travelan Protects Against Shigella in Primates 5 Sep 2018 9:24AM $0.335 $0.046 fallen by 86.27%
$15 Preliminary Final Report 30 Aug 2018 9:51AM $0.340 $0.046 fallen by 86.47%
$15 Initial Director's Interest Notice (RJB) 31 Jul 2018 9:52AM $0.375 $0.046 fallen by 87.73%
$15 Change in substantial holding 30 Jul 2018 1:16PM $0.380 $0.046 fallen by 87.89%
$15 Immuron Reports Record Revenue 25 Jul 2018 10:05AM $0.385 $0.046 fallen by 88.05%
$15 Appendix 3B ESOP 17 Jul 2018 10:17AM $0.360 $0.046 fallen by 87.22%
$15 US Department of Defense Research Collaboration Moves Ahead 16 Jul 2018 9:38AM $0.385 $0.046 fallen by 88.05%
$15 European Patent Gramted for Nash Treatment 11 Jul 2018 11:54AM $0.330 $0.046 fallen by 86.06%

476 - 500 of 782 results

Page 20 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.